Summary of Study ST001987
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001263. The data can be accessed directly via it's Project DOI: 10.21228/M8FX3C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001987 |
Study Title | Transcriptomic and lipidomic analysis unravels the response of Faecalibacterium prausnitzii to calcium palmitate |
Study Summary | Infant formula is a suggested alternative to human milk if breastfeeding is not an option; vegetable oil blends are commonly used in infant formula (IF) to replace dairy fat, which can induce the formation of the poorly soluble soap calcium palmitate (CP) in the infant’s gut. Previously, we observed that CP at a low concentration of 0.01 mg/ml inhibits the growth of dominant infant bacteria such as Faecalibacterium prausnitzii both during the exponential phase as well as in the stationary phase. Here, we investigate the underlying mechanism of the CP inhibition on infant-gut bacteria using F. prausnitzii as a model by analysing its growth at a transcriptomic and lipidomic level. |
Institute | University of Groningen |
Last Name | Horvatovich |
First Name | Péter |
Address | Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands |
p.l.horvatovich@rug.nl | |
Phone | +31 (0)50 363 3341 |
Submit Date | 2021-11-12 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2021-12-15 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001263 |
Project DOI: | doi: 10.21228/M8FX3C |
Project Title: | Transcriptomic and lipidomic analysis unravels the response of Faecalibacterium prausnitzii to calcium palmitate |
Project Summary: | Infant formula is a suggested alternative to human milk if breastfeeding is not an option; vegetable oil blends are commonly used in infant formula (IF) to replace dairy fat, which can induce the formation of the poorly soluble soap calcium palmitate (CP) in the infant’s gut. Previously, we observed that CP at a low concentration of 0.01 mg/ml inhibits the growth of dominant infant bacteria such as Faecalibacterium prausnitzii both during the exponential phase as well as in the stationary phase. Here, we investigate the underlying mechanism of the CP inhibition on infant-gut bacteria using F. prausnitzii as a model by analysing its growth at a transcriptomic and lipidomic level. |
Institute: | University of Groningen |
Last Name: | Horvatovich |
First Name: | Péter |
Address: | Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands |
Email: | p.l.horvatovich@rug.nl |
Phone: | +31 (0)50 363 3341 |
Subject:
Subject ID: | SU002068 |
Subject Type: | Bacteria |
Subject Species: | Faecalibacterium prausnitzii |
Factors:
Subject type: Bacteria; Subject species: Faecalibacterium prausnitzii (Factor headings shown in green)
mb_sample_id | local_sample_id | Factor |
---|---|---|
SA185849 | Neg38 | CP0Hour16 Negative |
SA185850 | Neg41 | CP0Hour16 Negative |
SA185851 | Neg8 | CP0Hour16 Negative |
SA185852 | Neg35 | CP0Hour16 Negative |
SA185853 | Neg42 | CP0Hour16 Negative |
SA185854 | Neg26 | CP0Hour16 Negative |
SA185855 | Neg18 | CP0Hour16 Negative |
SA185856 | Neg19 | CP0Hour16 Negative |
SA185857 | Neg20 | CP0Hour16 Negative |
SA185858 | Neg7 | CP0Hour16 Negative |
SA185859 | Neg30 | CP0Hour16 Negative |
SA185860 | Neg13 | CP0Hour16 Negative |
SA185861 | Pos26 | CP0Hour16 Positive |
SA185862 | Pos20 | CP0Hour16 Positive |
SA185863 | Pos19 | CP0Hour16 Positive |
SA185864 | Pos18 | CP0Hour16 Positive |
SA185865 | Pos35 | CP0Hour16 Positive |
SA185866 | Pos38 | CP0Hour16 Positive |
SA185867 | Pos7 | CP0Hour16 Positive |
SA185868 | Pos8 | CP0Hour16 Positive |
SA185869 | Pos42 | CP0Hour16 Positive |
SA185870 | Pos41 | CP0Hour16 Positive |
SA185871 | Pos13 | CP0Hour16 Positive |
SA185872 | Pos30 | CP0Hour16 Positive |
SA185873 | Neg23 | CP0Hour5 Negative |
SA185874 | Neg29 | CP0Hour5 Negative |
SA185875 | Neg22 | CP0Hour5 Negative |
SA185876 | Neg21 | CP0Hour5 Negative |
SA185877 | Neg6 | CP0Hour5 Negative |
SA185878 | Neg33 | CP0Hour5 Negative |
SA185879 | Neg17 | CP0Hour5 Negative |
SA185880 | Neg16 | CP0Hour5 Negative |
SA185881 | Neg43 | CP0Hour5 Negative |
SA185882 | Neg5 | CP0Hour5 Negative |
SA185883 | Neg36 | CP0Hour5 Negative |
SA185884 | Neg37 | CP0Hour5 Negative |
SA185885 | Pos36 | CP0Hour5 Positive |
SA185886 | Pos37 | CP0Hour5 Positive |
SA185887 | Pos43 | CP0Hour5 Positive |
SA185888 | Pos33 | CP0Hour5 Positive |
SA185889 | Pos6 | CP0Hour5 Positive |
SA185890 | Pos21 | CP0Hour5 Positive |
SA185891 | Pos16 | CP0Hour5 Positive |
SA185892 | Pos17 | CP0Hour5 Positive |
SA185893 | Pos22 | CP0Hour5 Positive |
SA185894 | Pos23 | CP0Hour5 Positive |
SA185895 | Pos29 | CP0Hour5 Positive |
SA185896 | Pos5 | CP0Hour5 Positive |
SA185897 | Neg4 | CP2Hour16 Negative |
SA185898 | Neg39 | CP2Hour16 Negative |
SA185899 | Neg45 | CP2Hour16 Negative |
SA185900 | Neg47 | CP2Hour16 Negative |
SA185901 | Neg10 | CP2Hour16 Negative |
SA185902 | Neg32 | CP2Hour16 Negative |
SA185903 | Neg48 | CP2Hour16 Negative |
SA185904 | Neg31 | CP2Hour16 Negative |
SA185905 | Neg15 | CP2Hour16 Negative |
SA185906 | Neg12 | CP2Hour16 Negative |
SA185907 | Neg25 | CP2Hour16 Negative |
SA185908 | Neg27 | CP2Hour16 Negative |
SA185909 | Pos27 | CP2Hour16 Positive |
SA185910 | Pos25 | CP2Hour16 Positive |
SA185911 | Pos15 | CP2Hour16 Positive |
SA185912 | Pos31 | CP2Hour16 Positive |
SA185913 | Pos12 | CP2Hour16 Positive |
SA185914 | Pos39 | CP2Hour16 Positive |
SA185915 | Pos48 | CP2Hour16 Positive |
SA185916 | Pos10 | CP2Hour16 Positive |
SA185917 | Pos45 | CP2Hour16 Positive |
SA185918 | Pos4 | CP2Hour16 Positive |
SA185919 | Pos32 | CP2Hour16 Positive |
SA185920 | Pos47 | CP2Hour16 Positive |
SA185921 | Neg28 | CP2Hour5 Negative |
SA185922 | Neg2 | CP2Hour5 Negative |
SA185923 | Neg14 | CP2Hour5 Negative |
SA185924 | Neg11 | CP2Hour5 Negative |
SA185925 | Neg1 | CP2Hour5 Negative |
SA185926 | Neg24 | CP2Hour5 Negative |
SA185927 | Neg3 | CP2Hour5 Negative |
SA185928 | Neg46 | CP2Hour5 Negative |
SA185929 | Neg44 | CP2Hour5 Negative |
SA185930 | Neg40 | CP2Hour5 Negative |
SA185931 | Neg34 | CP2Hour5 Negative |
SA185932 | Neg9 | CP2Hour5 Negative |
SA185933 | Pos9 | CP2Hour5 Positive |
SA185934 | Pos34 | CP2Hour5 Positive |
SA185935 | Pos40 | CP2Hour5 Positive |
SA185936 | Pos44 | CP2Hour5 Positive |
SA185937 | Pos46 | CP2Hour5 Positive |
SA185938 | Pos3 | CP2Hour5 Positive |
SA185939 | Pos28 | CP2Hour5 Positive |
SA185940 | Pos11 | CP2Hour5 Positive |
SA185941 | Pos14 | CP2Hour5 Positive |
SA185942 | Pos2 | CP2Hour5 Positive |
SA185943 | Pos24 | CP2Hour5 Positive |
SA185944 | Pos1 | CP2Hour5 Positive |
Showing results 1 to 96 of 96 |
Collection:
Collection ID: | CO002061 |
Collection Summary: | Lipids were extracted using the MTBE method (Gil et al., 2018). The bacterial cell pellet was resuspended into 75 μL water, then it was incubated with 200 μL methanol and 625 μL MTBE (methyl tert-butyl ether) for 1 h on a shaker. The bacteria/methanol/MTBE mixture was further incubated with 100 μL water to induce phase separation. After 10 min centrifugation at 1000 × g, the upper organic phase was collected. The lower phase was re-extracted with 250 μL MTBE/methanol/water 10:3:2.5 v/v/v and incubated on a shaker for 30 min. After 3 min centrifugation at 1000 × g, the upper organic phase was collected. The combined organic phases containing the lipids were dried in a vacuum centrifuge at 30 ºC and then dissolved in 25 μL CHCl3/methanol/water 60:30:4.5 v/v/v. 75 μL isopropanol/acetonitrile/water 2:1:1 v/v/v was added to dilute the lipid solution. |
Sample Type: | Bacteria |
Collection Location: | University Medical Center Groningen (UMCG) |
Treatment:
Treatment ID: | TR002080 |
Treatment Summary: | The diluted lipid solution was separated using a Zorbax Eclipse Plus C18 column (1.8 μm, 50 × 2.1 mm) on an Acquity UPLC system (Waters, Manchester, UK). Mobile phases consisted of 10 mM ammonium formate in water/acetonitrile/formic acid 2:3:0.005 v/v/v (eluent A) and 10 mM ammonium formate in isopropanol/acetonitrile/formic acid 9:1:0.01 v/v/v (eluent B). Linear gradient elution was as follows: 0– 2 min from 40 to 43% eluent B, 2–12 min from 50 to 54% eluent B, 12-18 min from 70 to 99% eluent B, and 18–20 min 40% eluent B.. The column temperature was set at 55 °C, and the flow rate was 0.4 mL/min. One μL of sample was loaded to MaXis plus high-resolution QTof mass spectrometer (Bruker, Bremen, Germany), Lipids were detected by electrospray ionization in positive (ESI+) and negative mode (ESI-). |
Sample Preparation:
Sampleprep ID: | SP002074 |
Sampleprep Summary: | F. prausnitzii A2-165 (DSM 17677) was inoculated in YCFAG medium (Lopez-Siles et al, 2012), without (CP0) and with 0.01 mg/mL CP (CP2) (Wang et al., 2021) in an anaerobic chamber (80% N2, 12% CO2, and 8% H2) and incubated in the same chamber at 37°C. |
Combined analysis:
Analysis ID | AN003238 | AN003239 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Waters Acquity | Waters Acquity |
Column | Agilent Zorbax Eclipse Plus C18 (100 x 2.1mm, 1.8 um) | Agilent Zorbax Eclipse Plus C18 (100 x 2.1mm, 1.8 um) |
MS Type | ESI | ESI |
MS instrument type | QTOF | QTOF |
MS instrument name | Bruker maXis Impact qTOF | Bruker maXis Impact qTOF |
Ion Mode | POSITIVE | NEGATIVE |
Units | peak area | Peak area |
Chromatography:
Chromatography ID: | CH002388 |
Chromatography Summary: | The diluted lipid solution was separated using a Zorbax Eclipse Plus C18 column (1.8 μm, 50 × 2.1 mm) on an Acquity UPLC system (Waters, Manchester, UK). Mobile phases consisted of 10 mM ammonium formate in water/acetonitrile/formic acid 2:3:0.005 v/v/v (eluent A) and 10 mM ammonium formate in isopropanol/acetonitrile/formic acid 9:1:0.01 v/v/v (eluent B). Linear gradient elution was as follows: 0– 2 min from 40 to 43% eluent B, 2–12 min from 50 to 54% eluent B, 12-18 min from 70 to 99% eluent B, and 18–20 min 40% eluent B.. The column temperature was set at 55 °C, and the flow rate was 0.4 mL/min. One μL of sample was loaded to MaXis plus high-resolution QTof mass spectrometer (Bruker, Bremen, Germany), Lipids were detected by electrospray ionization in positive (ESI+) and negative mode (ESI-). |
Instrument Name: | Waters Acquity |
Column Name: | Agilent Zorbax Eclipse Plus C18 (100 x 2.1mm, 1.8 um) |
Column Temperature: | 55 |
Flow Gradient: | 0- 2 min from 40 to 43% eluent B, 2-12 min from 50 to 54% eluent B, 12-18 min from 70 to 99% eluent B, and 18-20 min 40% eluent B. |
Flow Rate: | 0.4 mL/min |
Solvent A: | 40% water/60% acetonitrile; 0.005% formic acid; 10 mM ammonium formate |
Solvent B: | 90% isopropanol/10% acetonitrile; 0.01% formic acid; 10 mM ammonium formate |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS003011 |
Analysis ID: | AN003238 |
Instrument Name: | Bruker maXis Impact qTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Peak detection and statistics. The MSConvert (Version: 3.0.18234) tool from the ProteoWizard package was used to convert the raw files from the Bruker QToF into .mzML files. |
Ion Mode: | POSITIVE |
MS ID: | MS003012 |
Analysis ID: | AN003239 |
Instrument Name: | Bruker maXis Impact qTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Peak detection and statistics. The MSConvert (Version: 3.0.18234) tool from the ProteoWizard package was used to convert the raw files from the Bruker QToF into .mzML files. |
Ion Mode: | NEGATIVE |